SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $328,323 | -90.6% | 202,674 | -45.2% | 0.00% | -93.9% |
| Q3 2020 | $3,496,000 | +5.5% | 370,000 | 0.0% | 0.03% | -5.7% |
| Q2 2020 | $3,315,000 | -22.1% | 370,000 | -28.8% | 0.04% | -25.5% |
| Q1 2020 | $4,255,000 | -2.2% | 520,000 | 0.0% | 0.05% | 0.0% |
| Q4 2019 | $4,352,000 | -21.8% | 520,000 | -15.4% | 0.05% | -36.5% |
| Q3 2019 | $5,566,000 | +25.1% | 615,000 | +48.2% | 0.07% | +32.1% |
| Q2 2019 | $4,450,000 | +216.1% | 415,000 | +159.4% | 0.06% | +115.4% |
| Q2 2017 | $1,408,000 | +0.3% | 160,000 | -40.7% | 0.03% | -3.7% |
| Q1 2017 | $1,404,000 | +130.2% | 270,000 | +35.0% | 0.03% | +92.9% |
| Q4 2016 | $610,000 | -34.1% | 200,000 | 0.0% | 0.01% | -36.4% |
| Q3 2016 | $926,000 | -20.0% | 200,000 | 0.0% | 0.02% | -26.7% |
| Q2 2016 | $1,158,000 | -3.7% | 200,000 | 0.0% | 0.03% | 0.0% |
| Q1 2016 | $1,203,000 | -34.1% | 200,000 | +66.7% | 0.03% | -21.1% |
| Q4 2014 | $1,825,000 | – | 120,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WASATCH ADVISORS LP | 17,986,781 | $10,788,471 | 0.07% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 254,257 | $12,790 | 0.03% |
| Long Focus Capital Management, LLC | 1,372,000 | $822,926 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 559,731 | $336 | 0.03% |
| Rokos Capital Management LLP | 6,474,348 | $3,940,936 | 0.03% |
| Golden State Equity Partners | 166,265 | $99,726 | 0.03% |
| State of Wyoming | 92,360 | $55,398 | 0.01% |
| ExodusPoint Capital Management, LP | 1,890,425 | $1,134 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 2,927,769 | $1,753 | 0.01% |
| Fort Sheridan Advisors LLC | 53,831 | $32,288 | 0.01% |